NCT02096068 - Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 17, 2018

Study Completion Date

July 31, 2018

Conditions

DeliriumPostoperative Cognitive Deficit (POCD)

Interventions

DRUG

Dexmedetomidine (Dexdor®)

Dexmedetomidine (Dexdor 100 micrograms/ml concentrate for solution for infusion)

DRUG

0.9% Sodium Chloride

Solution for infusion: Sodium Chloride : 9.0 g/l; Each ml contains 9 mg sodium chloride mmol/l : Na+ : 154. Cl-: 154.

Trial Locations (1)

13353

Department of Anesthesiology and Operative Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charité- Universitätsmedizin, Berlin